Media & Publications

December 4, 2015

Microparticles bearing encephalitogenic peptides induce T-cell tolerance and ameliorate experimental autoimmune encephalomyelitis

Read More
December 3, 2015

Cour Pharma Presents Scientific Poster on Breakthrough Celiac Treatment at 16th Annual International Celiac Disease Symposium

Download Poster Here
Read More
October 19, 2015

Cour Pharmaceuticals Releases Data on Potential Breakthrough Treatment for Celiac Disease

Proprietary Antigen-specific Nanoparticles and Cure for Celiac Disease Chicago (June 22, 2015) – Cour Pharmaceutical Development Company today announced new data from a preclinical live animal study demonstrating a breakthrough...
Read More
1 2